Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression
Thorsten Mikoteit, Johannes Beck, Anne Eckert, et al.
Psychopharmacology (2014) Vol. 231, Iss. 15, pp. 2955-2965
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

BDNF in sleep, insomnia, and sleep deprivation
Karen Schmitt, Edith Holsboer‐Trachsler, Anne Eckert
Annals of Medicine (2016) Vol. 48, Iss. 1-2, pp. 42-51
Closed Access | Times Cited: 214
The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes
Ryan E. Ross, Catherine J. VanDerwerker, Michael E. Saladin, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 298-328
Open Access | Times Cited: 89
Vitamin D and mental health in children and adolescents
Manuel Föcker, Jochen Antel, Stefanie Ring, et al.
European Child & Adolescent Psychiatry (2017) Vol. 26, Iss. 9, pp. 1043-1066
Closed Access | Times Cited: 99
Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants
Florian Duclot, Mohamed Kabbaj
Journal of Experimental Biology (2015) Vol. 218, Iss. 1, pp. 21-31
Open Access | Times Cited: 96
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
Anna Mosiołek, Jadwiga Mosiołek, Sławomir Jakima, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3377-3377
Open Access | Times Cited: 56
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 26
Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression
Guoqing Zhao, Chen Zhang, Jun Chen, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 7, pp. 5573-5582
Closed Access | Times Cited: 69
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder
Mohammad Haghighi, Saeed Khodakarami, Leila Jahangard, et al.
Journal of Psychiatric Research (2014) Vol. 58, pp. 109-114
Closed Access | Times Cited: 64
Forkhead box O transcription factors as possible mediators in the development of major depression
Haitao Wang, Rémi Quirion, Peter J. Little, et al.
Neuropharmacology (2015) Vol. 99, pp. 527-537
Closed Access | Times Cited: 55
Elucidating the Possible Role of FoxO in Depression
Tarapati Rana, Tapan Behl, Aayush Sehgal, et al.
Neurochemical Research (2021) Vol. 46, Iss. 11, pp. 2761-2775
Closed Access | Times Cited: 38
Reversal of corticosterone-induced BDNF alterations by the natural antioxidant alpha-lipoic acid alone and combined with desvenlafaxine: Emphasis on the neurotrophic hypothesis of depression
Caren Nádia Soares de Sousa, L.N. Meneses, Germana Silva Vasconcelos, et al.
Psychiatry Research (2015) Vol. 230, Iss. 2, pp. 211-219
Closed Access | Times Cited: 49
Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial
Serge Brand, Vahid Farnia, Jalal Shakeri, et al.
Neuropsychiatric Disease and Treatment (2015), pp. 625-625
Open Access | Times Cited: 48
Rodent models of treatment-resistant depression
Barbara J. Caldarone, Venetia Zachariou, Sarah L. King
European Journal of Pharmacology (2014) Vol. 753, pp. 51-65
Open Access | Times Cited: 47
Neurotrophic factors in depression in response to treatment
Henriette N. Buttenschøn, Leslie Foldager, Betina Elfving, et al.
Journal of Affective Disorders (2015) Vol. 183, pp. 287-294
Closed Access | Times Cited: 44
Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial
Ali Ghaleiha, Hassan Davari, Leila Jahangard, et al.
European Archives of Psychiatry and Clinical Neuroscience (2016) Vol. 266, Iss. 8, pp. 695-702
Closed Access | Times Cited: 44
Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder
Iraj Salehi, Seyed Mohammad Hosseini, Mohammad Haghighi, et al.
Journal of Psychiatric Research (2016) Vol. 76, pp. 1-8
Closed Access | Times Cited: 41
Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder
Jung Lee, Kyung Hwa Lee, Seong Hae Kim, et al.
Journal of Affective Disorders (2020) Vol. 265, pp. 325-332
Closed Access | Times Cited: 33
Investigating Neuroplasticity Changes Reflected by BDNF Levels in Astrocyte-Derived Extracellular Vesicles in Patients with Depression
Kun Li, Kun Wang, Shu‐xian Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8971-8985
Open Access | Times Cited: 4
Exploring the prospective association of serum interleukin-1β and brain-derived neurotrophic factor with antidepressant treatment response
C.K. Cho, Ji Hyeon Jeon, Hee-Ju Kang, et al.
European Neuropsychopharmacology (2025) Vol. 95, pp. 33-39
Closed Access
Limbic white matter microstructure plasticity reflects recovery from depression
Tobias Bracht, Derek K. Jones, Thomas Müller, et al.
Journal of Affective Disorders (2014) Vol. 170, pp. 143-149
Closed Access | Times Cited: 41
RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder
Iraj Salehi, Seyed Mohammad Hosseini, Mohammad Haghighi, et al.
Journal of Psychiatric Research (2014) Vol. 57, pp. 117-124
Open Access | Times Cited: 40
Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women
Jacob D. Meyer, Kelli F. Koltyn, Aaron J. Stegner, et al.
Psychoneuroendocrinology (2016) Vol. 74, pp. 286-294
Closed Access | Times Cited: 38
Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
Paolo Olgiati, Alessandro Serretti, Daniel Souery, et al.
Journal of Affective Disorders (2017) Vol. 227, pp. 777-786
Closed Access | Times Cited: 36
Blood-based immune-endocrine biomarkers of treatment response in depression
Man K. Chan, Jason D. Cooper, Mariska Bot, et al.
Journal of Psychiatric Research (2016) Vol. 83, pp. 249-259
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top